BEIJING—China sent a stern warning to global companies doing business in the country, accusing a foreign executive of fostering a culture of bribery at GlaxoSmithKline PLC's Chinese arm that police said resulted in hundreds of millions of dollars in new business.. Experts say the unusual move signals that China's efforts to tame its pharmaceutical market—and, more broadly, to stamp out pervasive corruption and bribery in the world's No. 2 economy—could increasingly put foreign executives in the government's sights.